Natera IncNTRA
Price$408.47

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.7B+59.5% YoYTTM through 30 Jun 2026
Net Income -$192.3MTTM through 30 Jun 2026
Free Cash Flow $84.2MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin-8.8%
Operating Margin-10.7%
Net Margin-7.1%

Returns

-10.6%ROE
-7.2%ROA

Balance Sheet Health

Debt / Equity0.04x
Current Ratio3.00x
Net Debt-$1Bnet cash position
Cash & Equivalents$1.1B

Quality Metrics

Altman Z-Score40.06
Piotroski F-Score5 / 9
FCF Margin3.1%
Rule of 4010.2
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.3B
Diluted EPS-$1.35TTM
'19'20'21'22'23'24'25
FY2025: $-1.52

Dividend

No dividend

Capital Allocation

R&D Spend$787.4M
Capex Intensity5.3%

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.